Novel Biomarkers for Thrombosis Risk Prediction in Non–Small-Cell Lung Cancer: Insights from Recent Evidence
Venous thromboembolism (VTE) represents a significant cause of morbidity and mortality in patients with cancer,...
Most Read
The Evolving Landscape of Cerebral Venous Sinus Thrombosis: Emerging Risk Factors and Treatments
Cerebral venous sinus thrombosis (CVST) is a rare yet serious condition, representing an uncommon manifestation of...
Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
Disseminated Intravascular coagulation in solid and hematological cancers
Introduction There is a clear relationship between malignancy and deranged coagulation. Patients with cancer are at...
Modeling predictors and outcomes in myeloproliferative neoplasms and thrombosis
Myeloproliferative neoplasms (MPNs) are characterized by clonal expansion of abnormal hematopoietic stem cells, which...
Flash Interviews from the 11th ICTHIC
Anna-Karin Olsson: What are the main take-home messages from “Neutrophil extracellular traps promote...
Risk prediction for cancer‐associated thrombosis: A talk with Prof. Pabinger
Professor Pabinger is a hematologist at the University of Vienna, where she studies cancer and thrombosis. During the...
Recording available for the webinar “Updates in Cancer-Associated Thrombosis”
You can now watch the recording of “updates in cancer-associated thrombosis” webinar. Check...
SAVE THE DATE – The 13th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 13th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will next be...
The 10th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will next be held on 17–19...